CSI Market
Sign In | Register

Quince Therapeutics Inc (QNCX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access QNCX quarterly Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Quince Therapeutics Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-83.98
Depreciation & amortization0.14
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability7.64
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation5.11
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants20.99
Lease And Rental Expense-
Investment Income Amortization Of Discount-
Loss On Disposal-
Investment Income Net Amortization Of Discount And Premium-1.01
Right Of Use Assets Operating Leases And Operating Lease Liabilities0.10
Increase Decrease In Fair Value Of Borrowings-
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.94
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities5.78
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.01
Other Working Capital4.95
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.81
Discontinued operations0.00
Net Cash flow from Operating Activities-41.43
Investing Activities
Capital Expenditures-0.35
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities58.00
Payments to Acquire Available-for-sale Securities, Debt-34.42
Real Estate Investments0.00
Payments To Acquire Notes Receivable-
Advancement Of Notes Receivable-
Cash Paid In Acquisition For Business Net Of Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities23.23
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.22
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Finance Lease Principal Payments-
Proceeds From Issuance Of Common Stock Common Warrants And Pre- Funded Warrants11.43
Sale Of Stock Consideration Received On Transaction6.26
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities17.91
Effect of exchange rate on cash flow-0.11
Discontinued operations0.00
Free Cash Flow-41.78
Total Cash Flow-0.40
4 historic quarters locked

Sign in to unlock the full Quince Therapeutics Inc cash flow history.

Sign In Create Free Account

About Quince Therapeutics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-151364

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License